Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04180202 · ClinicalTrials.gov registry record
Comparison of Non-invasive Vs. Invasive Hemodynamic Measurements
A clinical trial, sponsored by Nihon Kohden.
- Terminated
- Registry status
- 8
- Enrollment target
NCT04180202: Clinical Trial study, sponsored by Nihon Kohden.
NCT04180202 is a clinical trial that was terminated before completion, run by Nihon Kohden. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04180202 was terminated before completion, sponsored by Nihon Kohden.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
Comparison of a non-invasive method of measuring central venous pressure to the conventional modality of invasive central venous pressure.
Primary Outcome
Evaluate sensitivity and specificity of ezCVP indication based on the case where CVP is in a 'low range' (0 \< CVP \< 10 mmHg) or 'high range' (\>= 10 mmHg)
Interventions
- DEVICE Non-invasive central venous pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-01-16 |
| Est. Completion | 2022-06-20 |
Why NCT04180202 stopped before completion
NCT04180202 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Non-invasive central venous pressure is the first listed.
NCT04180202 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04180202 about?
NCT04180202 is a clinical study titled "Comparison of Non-invasive Vs. Invasive Hemodynamic Measurements". Comparison of a non-invasive method of measuring central venous pressure to the conventional modality of invasive central venous pressure.
What is the current status of trial NCT04180202?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2020-01-16. Estimated completion is 2022-06-20.
What interventions are being tested in trial NCT04180202?
The interventions under investigation include: Non-invasive central venous pressure (DEVICE).
Who is sponsoring clinical trial NCT04180202?
This trial is sponsored by Nihon Kohden, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI